Who should receive Prevnar 13?

Advertisement
Advertisement
Prevnar 13 (pneumococcal conjugate vaccine) is a vaccine that protects against pneumonia caused by 13 strains of pneumococcal bacteria. It is intended for children six weeks to 5 years of age, and for adults over 19 years of age who have compromised immune systems due to HIV, cancer or kidney disease. The U.S. Food and Drug Administration has also approved Prevnar 13 for use in adults over 50 years of age, but it should not be considered a substitute for the pneumococcal polysaccharide vaccine administered to older persons. Prevnar 13 is not recommended for use in pregnant women. 

Continue Learning about Vaccine

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.